These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 30061637)
1. Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways. Ohno Y; Shingyoku S; Miyake S; Tanaka A; Fudesaka S; Shimizu Y; Yoshifuji A; Yamawaki Y; Yoshida S; Tanaka S; Sakura K; Tanaka T Oncogene; 2018 Dec; 37(49):6357-6367. PubMed ID: 30061637 [TBL] [Abstract][Full Text] [Related]
2. Sphere culture of murine lung cancer cell lines are enriched with cancer initiating cells. Morrison BJ; Steel JC; Morris JC PLoS One; 2012; 7(11):e49752. PubMed ID: 23152931 [TBL] [Abstract][Full Text] [Related]
3. Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells. Liu J; Xiao Z; Wong SK; Tin VP; Ho KY; Wang J; Sham MH; Wong MP Oncotarget; 2013 Oct; 4(10):1698-1711. PubMed ID: 24091605 [TBL] [Abstract][Full Text] [Related]
4. Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDH(high)CD44(+) phenotype and sphere-forming capacity. Cortes-Dericks L; Froment L; Boesch R; Schmid RA; Karoubi G BMC Cancer; 2014 Apr; 14():304. PubMed ID: 24884875 [TBL] [Abstract][Full Text] [Related]
5. Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population. Yasuda K; Torigoe T; Morita R; Kuroda T; Takahashi A; Matsuzaki J; Kochin V; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N PLoS One; 2013; 8(8):e68187. PubMed ID: 23967051 [TBL] [Abstract][Full Text] [Related]
6. The inhibition of FGF receptor 1 activity mediates sorafenib antiproliferative effects in human malignant pleural mesothelioma tumor-initiating cells. Pattarozzi A; Carra E; Favoni RE; Würth R; Marubbi D; Filiberti RA; Mutti L; Florio T; Barbieri F; Daga A Stem Cell Res Ther; 2017 May; 8(1):119. PubMed ID: 28545562 [TBL] [Abstract][Full Text] [Related]
7. Characterisation of mesothelioma-initiating cells and their susceptibility to anti-cancer agents. Pasdar EA; Smits M; Stapelberg M; Bajzikova M; Stantic M; Goodwin J; Yan B; Stursa J; Kovarova J; Sachaphibulkij K; Bezawork-Geleta A; Sobol M; Filimonenko A; Tomasetti M; Zobalova R; Hozak P; Dong LF; Neuzil J PLoS One; 2015; 10(5):e0119549. PubMed ID: 25932953 [TBL] [Abstract][Full Text] [Related]
8. CD44+ cancer stem-like cells in EBV-associated nasopharyngeal carcinoma. Lun SW; Cheung ST; Cheung PF; To KF; Woo JK; Choy KW; Chow C; Cheung CC; Chung GT; Cheng AS; Ko CW; Tsao SW; Busson P; Ng MH; Lo KW PLoS One; 2012; 7(12):e52426. PubMed ID: 23285037 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells. Cheng W; Liu T; Wan X; Gao Y; Wang H FEBS J; 2012 Jun; 279(11):2047-59. PubMed ID: 22498306 [TBL] [Abstract][Full Text] [Related]
10. Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2. Keysar SB; Le PN; Miller B; Jackson BC; Eagles JR; Nieto C; Kim J; Tang B; Glogowska MJ; Morton JJ; Padilla-Just N; Gomez K; Warnock E; Reisinger J; Arcaroli JJ; Messersmith WA; Wakefield LM; Gao D; Tan AC; Serracino H; Vasiliou V; Roop DR; Wang XJ; Jimeno A J Natl Cancer Inst; 2017 Jan; 109(1):. PubMed ID: 27634934 [TBL] [Abstract][Full Text] [Related]
11. Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8⁺ T cells. Visus C; Wang Y; Lozano-Leon A; Ferris RL; Silver S; Szczepanski MJ; Brand RE; Ferrone CR; Whiteside TL; Ferrone S; DeLeo AB; Wang X Clin Cancer Res; 2011 Oct; 17(19):6174-84. PubMed ID: 21856769 [TBL] [Abstract][Full Text] [Related]
12. Identification of gastric cancer stem cells using the cell surface marker CD44. Takaishi S; Okumura T; Tu S; Wang SS; Shibata W; Vigneshwaran R; Gordon SA; Shimada Y; Wang TC Stem Cells; 2009 May; 27(5):1006-20. PubMed ID: 19415765 [TBL] [Abstract][Full Text] [Related]
13. Induction of the stem-like cell regulator CD44 by Rho kinase inhibition contributes to the maintenance of colon cancer-initiating cells. Ohata H; Ishiguro T; Aihara Y; Sato A; Sakai H; Sekine S; Taniguchi H; Akasu T; Fujita S; Nakagama H; Okamoto K Cancer Res; 2012 Oct; 72(19):5101-10. PubMed ID: 23002207 [TBL] [Abstract][Full Text] [Related]
14. LY6/PLAUR domain containing 3 has a role in the maintenance of colorectal cancer stem-like cells. Wang L; Hirohashi Y; Ogawa T; Shen M; Takeda R; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T Biochem Biophys Res Commun; 2017 Apr; 486(2):232-238. PubMed ID: 28238780 [TBL] [Abstract][Full Text] [Related]
15. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells. Bourguignon LYW; Earle C; Shiina M Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080 [TBL] [Abstract][Full Text] [Related]
16. Aldehyde dehydrogenase high gastric cancer stem cells are resistant to chemotherapy. Nishikawa S; Konno M; Hamabe A; Hasegawa S; Kano Y; Ohta K; Fukusumi T; Sakai D; Kudo T; Haraguchi N; Satoh T; Takiguchi S; Mori M; Doki Y; Ishii H Int J Oncol; 2013 Apr; 42(4):1437-42. PubMed ID: 23440340 [TBL] [Abstract][Full Text] [Related]
17. Cancer-initiating cells derived from human rectal adenocarcinoma tissues carry mesenchymal phenotypes and resist drug therapies. Fan CW; Chen T; Shang YN; Gu YZ; Zhang SL; Lu R; OuYang SR; Zhou X; Li Y; Meng WT; Hu JK; Lu Y; Sun XF; Bu H; Zhou ZG; Mo XM Cell Death Dis; 2013 Oct; 4(10):e828. PubMed ID: 24091671 [TBL] [Abstract][Full Text] [Related]
18. Small proline-rich protein-1B is overexpressed in human oral squamous cell cancer stem-like cells and is related to their growth through activation of MAP kinase signal. Michifuri Y; Hirohashi Y; Torigoe T; Miyazaki A; Fujino J; Tamura Y; Tsukahara T; Kanaseki T; Kobayashi J; Sasaki T; Takahashi A; Nakamori K; Yamaguchi A; Hiratsuka H; Sato N Biochem Biophys Res Commun; 2013 Sep; 439(1):96-102. PubMed ID: 23954638 [TBL] [Abstract][Full Text] [Related]
19. Aldehyde dehydrogenase activity in cancer stem cells from canine mammary carcinoma cell lines. Michishita M; Akiyoshi R; Suemizu H; Nakagawa T; Sasaki N; Takemitsu H; Arai T; Takahashi K Vet J; 2012 Aug; 193(2):508-13. PubMed ID: 22326935 [TBL] [Abstract][Full Text] [Related]
20. Trametinib plus 4-Methylumbelliferone Exhibits Antitumor Effects by ERK Blockade and CD44 Downregulation and Affects PD-1 and PD-L1 in Malignant Pleural Mesothelioma. Cho H; Matsumoto S; Fujita Y; Kuroda A; Menju T; Sonobe M; Kondo N; Torii I; Nakano T; Lara PN; Gandara DR; Date H; Hasegawa S J Thorac Oncol; 2017 Mar; 12(3):477-490. PubMed ID: 27867002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]